Disclosures for "Mechanism of Action, Preclinical Efficacy, and Safety Evaluation of ACP-711 (SAN711): A Novel GABAA Subunit α3 Selective Modulator"
-
Dr. Amrutkar has stock in Saniona.
-
Dr. Sandager Nielsen has received personal compensation for serving as an employee of Saniona. Dr. Sandager Nielsen has stock in Saniona.
-
Mr. Dyhring has nothing to disclose.
-
Mr. Jacobsen has received personal compensation for serving as an employee of Saniona. Mr. Jacobsen has stock in Saniona.
-
Mr. Larsen has received personal compensation for serving as an employee of Saniona A/S. Mr. Larsen has stock in Saniona A/S.
-
Dr. Muglia has received personal compensation for serving as an employee of Saniona. Dr. Muglia has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Grin therapeutics. Dr. Muglia has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Saniona A/S. Dr. Muglia has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Grin therapeutics. Dr. Muglia has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Saniona. Dr. Muglia has stock in Saniona. Dr. Muglia has stock in Grin therapeutics.
-
Dr. Pathak has received personal compensation for serving as an employee of Acadia Pharmaceuticals.
-
Dr. Lin has received personal compensation for serving as an employee of Acadia Pharmaceuticals.
-
Dr. Hofbauer has received personal compensation for serving as an employee of Acadia Pharmaceuticals. Dr. Hofbauer has stock in Acadia Pharmaceuticals.